Literature DB >> 27026134

Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal.

Kwame K Asare1, Johnson N Boampong2, Nancy O Duah3, Richmond Afoakwah4, Rakesh Sehgal5, Neils B Quashie6.   

Abstract

Unlike other countries, the chloroquine resistant marker Pfcrt T76 mutant has remained fairly stable in Ghana several years after official disuse of chloroquine. Certain mutations in Pfmdr1 may potentiate Pfcrt T76, offering a possible explanation for this observation. To understand the phenomenon, the co-existence of mutations in Pfmdr1 with Pfcrt T76 in Ghanaian Plasmodium falciparum isolates was studied. The reported presence of parasites with reduced sensitivity to amodiaquine and quinine in the country was also studied. Blood samples collected from confirmed malaria patients presenting at health facilities in two distinct ecological zones were analyzed. The prevalence of Pfcrt K76T and the five point mutations in Pfmdr1 were determined using nested PCR followed by RFLP analysis. The association between genes was determined by chi square analysis, and synergism between the two genes was ascertained using the Jonckheere-Terptra (J-T) test followed by Monte Carlo simulation (MCS). Nearly fifty-four percent (53.7%) of the P. falciparum isolates examined had the Pfcrt T76 gene, out of which 18.3% had both K76 and T76 alleles. Mutations at codon 86, 184, 1034, 1042 and 1246 of the Pfmdr1 gene were detected in 36.0%, 87.9%, 71.0%, 91.6% and 8.4% of the isolates, respectively. The haplotypes of Pfmdr1 present were NFCDD (43.46%), YFCDD (27.57%), NFSDD (7.48%), NYSNY (5.14%) and YFSDD (4.67%). Pfcrt T76 was significantly associated with a double mutation at codon 86 and 184 of Pfmdr1 (YF; χ2=18.045, p=0.006). Associations were observed between Pfcrt K76T and Pfmdr1 triple mutation at codons 86, 184 and 1034 (NFC; χ2=13.770, p=0.032 and YFC; χ2=16.489, p=0.011). The J-T test showed significant synergism between Pfcrt 76 and Pfmdr1 polymorphisms (p<0.0001), which was confirmed by MCS at 99% CI. Synergism between Pfcrt and Pfmdr1 mutant genes could account for the slow recovery of chloroquine sensitive P. falciparum in Ghana. The same phenomenon could explain resistance to amodiaquine and quinine. The outcomes of this study also indicated a possible emergence of artemether-lumefantrine resistance in Ghana.
Copyright © 2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amodiaquine; Chloroquine; Drug resistance; Gene; Haplotype; Malaria; Pfcrt; Pfmdr1; Plasmodium falciparum; Quinine; Recovery; Synergism

Mesh:

Substances:

Year:  2016        PMID: 27026134     DOI: 10.1016/j.jiph.2016.02.004

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  4 in total

1.  Efficacy of Artemether-Lumefantrine on various Plasmodium falciparum Kelch 13 and Pfmdr1 genes isolated in Ghana.

Authors:  Enoch Aninagyei; Comfort Dede Tetteh; Martin Oppong; Alex Boye; Desmond Omane Acheampong
Journal:  Parasite Epidemiol Control       Date:  2020-10-26

2.  Polymorphism analysis of pfmdr1 gene in Plasmodium falciparum isolates 11 years post-adoption of artemisinin-based combination therapy in Saudi Arabia.

Authors:  Hesham M Al-Mekhlafi; Aymen M Madkhali; Ahmed A Abdulhaq; Wahib M Atroosh; Ahmad Hassn Ghzwani; Khalid Ammash Zain; Khalid Y Ghailan; Hassan A Hamali; Abdullah A Mobarki; Talal H Alharazi; Zaki M Eisa; Yee-Ling Lau
Journal:  Sci Rep       Date:  2022-01-11       Impact factor: 4.379

3.  The emergence of chloroquine-sensitive Plasmodium falciparum is influenced by selected communities in some parts of the Central Region of Ghana.

Authors:  Kwame Kumi Asare; Justice Africa; Jennifer Mbata; Yeboah Kwaku Opoku
Journal:  Malar J       Date:  2021-11-25       Impact factor: 2.979

4.  Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfcrt and pfmdr1 genes in isolates from Honduras and Nicaragua, 2018-2021.

Authors:  Gustavo Fontecha; Alejandra Pinto; Osman Archaga; Sergio Betancourth; Lenin Escober; Jessica Henríquez; Hugo O Valdivia; Alberto Montoya; Rosa Elena Mejía
Journal:  Malar J       Date:  2021-12-14       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.